Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse MKT  >  Lannett Company, Inc.    LCI

LANNETT COMPANY, INC. (LCI)
Mes dernières consult.
Most popular
  Report  
 SummaryNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Financials (USD)
Sales 2018 687 M
EBIT 2018 228 M
Net income 2018 58,5 M
Debt 2018 724 M
Yield 2018 -
Sales 2019 676 M
EBIT 2019 195 M
Net income 2019 82,7 M
Debt 2019 670 M
Yield 2019 -
P/E ratio 2018 8,63
P/E ratio 2019 7,62
EV / Sales2018 1,78x
EV / Sales2019 1,73x
Capitalization 500 M
More Financials
Company
Lannett Co., Inc. engages in the development, manufacture, market, and distribution of generic pharmaceutical products.The firm also manufactures oral dosage forms including, tablets and capsules.Its pharmaceutical products are distributed to drug wholesalers, chain drug retailers, private label... 
Sector
Pharmaceuticals
Calendar
08/29Earnings Release
More about the company
Surperformance© ratings of Lannett Company, Inc.
Trading Rating : Investor Rating :
More Ratings
Latest news on LANNETT COMPANY, INC.
07/11Free Stock Performance Review on Mallinckrodt and Three Additional Generic Dr..
AC
07/04LANNETT : Announces Restructuring Plan of Cody Laboratories Subsidiary
AQ
06/29LANNETT CO INC : Costs Associated with Exit or Disposal Activities, Material Imp..
AQ
06/29LANNETT : Announces Restructuring Plan Of Cody Laboratories Subsidiary
PR
06/22LANNETT CO INC : Change in Directors or Principal Officers, Financial Statements..
AQ
06/15INSIDER TRADING ACTIVITY LANNETT COM : LCI) – VP Sold 11,667 shares of Sto..
AQ
06/05LANNETT : Receives FDA Approval for Levofloxacin Oral Solution; Imminent Launch ..
AQ
06/01LANNETT : Receives FDA Approval For Levofloxacin Oral Solution; Imminent Launch ..
PR
05/21LANNETT : Receives FDA Approval For Dronabinol Capsules
PR
05/18LANNETT CO INC : Other Events (form 8-K)
AQ
More news
Sector news : Pharmaceuticals - NEC
07/17JOHNSON & JOHNSON : J&J beats quarterly expectations on drug sales surge, shares..
RE
07/17JOHNSON & JOHNSON : Pharma Business Fuels Sales Growth -- Update
DJ
07/17Johnson & Johnson on Track for Largest Intraday Percent Increase Since Jan 20..
DJ
07/17ABBVIE : Signs Humira Patent License with Mylan
DJ
07/17JOHNSON & JOHNSON : Pharmaceuticals Business Delivers, but Company Lowers Sales ..
DJ
More sector news : Pharmaceuticals - NEC
Income Statement Evolution
Consensus
 
Mean consensus HOLD
Number of Analysts 7
Average target price 23,0 $
Spread / Average Target 75%
EPS Revisions
Managers
NameTitle
Timothy C. Crew Chief Executive Officer & Director
Patrick G. LePore Chairman
John Abt Vice President, Chief Quality & Operations Officer
Martin P. Galvan CFO, Treasurer & Vice President-Finance
Robert Ehlinger Chief Information Officer & VP-logistics
Sector and Competitors
1st jan.Capitalization (M$)
LANNETT COMPANY, INC.0.00%517
JOHNSON & JOHNSON-9.87%337 763
PFIZER3.62%219 534
NOVARTIS-4.54%201 464
ROCHE HOLDING LTD.-5.78%201 132
MERCK AND COMPANY11.23%169 193